Xyzagen

Executive Summary

Xyzagen is a boutique pharmacokinetics consultancy and contract research organization (CRO) based in San Diego, offering integrated drug development services from early discovery through late-stage clinical programs. The company leverages its own wet lab and vivarium facilities to deliver model-informed drug development, bioanalysis, and regulatory strategy, with deep expertise in ophthalmology and neurology. Founded in 2018, Xyzagen currently supports Phase 2 clinical programs, positioning itself as a specialized partner for biopharma companies seeking expert pharmacokinetic support and efficient trial execution.

Upcoming Catalysts (preview)

• Q3 2026New client contract for Phase 2 ophthalmology trial70% success
• Q4 2026Expansion of bioanalytical lab capacity80% success
• H1 2027Strategic partnership with a neurology biotech60% success